series-b
Stage
1
Investors
About
Aptimmune Biologics develops mucosal vaccines targeting major viral diseases in swine, including Porcine Reproductive and Respiratory Syndrome virus (PRRSV), Swine Influenza A virus (IAV-S), and African Swine Fever virus (ASFV).
Explore Aptimmune Biologics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.